Crawford & Co Files 10-Q for Q2 2024
Ticker: CRD-B · Form: 10-Q · Filed: Aug 5, 2024 · CIK: 25475
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Crawford & Co's Q2 10-Q is in, showing segment performance for H1 2024 vs 2023.
AI Summary
Crawford & Company filed its 10-Q for the period ending June 30, 2024. The filing details financial performance across its operating segments, including International Operations and Platform Solutions. Specific financial data and segment performance are presented for the periods ending June 30, 2024, and June 30, 2023.
Why It Matters
This 10-Q filing provides investors and analysts with crucial financial updates on Crawford & Company's performance and operational segments for the second quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- Q2 2024 — Reporting Period (The second quarter of 2024 financial performance is detailed.)
- 2023-06-30 — Prior Period End Date (Comparative financial data from the previous year's second quarter.)
- 2024-01-01 — Year-to-Date Start (Beginning of the reporting period for year-to-date figures.)
Key Players & Entities
- Crawford & Co (company) — Filer of the 10-Q
- 20240630 (date) — End of reporting period
- 20240805 (date) — Filing date
- GA (location) — State of incorporation and business address
- 4043001000 (phone_number) — Business phone number
FAQ
What were the key financial highlights for Crawford & Company in Q2 2024?
The 10-Q filing for the period ending June 30, 2024, provides detailed financial information, but specific Q2 2024 financial highlights like revenue or net income figures are not explicitly stated in the provided header data.
Which operating segments are discussed in this 10-Q?
The filing references operating segments such as 'International Operations', 'Networks', and 'PlatformSolutions', with comparative data for periods ending June 30, 2024, and June 30, 2023.
What is Crawford & Company's fiscal year end?
Crawford & Company's fiscal year ends on December 31.
Where is Crawford & Company headquartered?
Crawford & Company's business address is located at 5335 Triangle Parkway, Peachtree Corners, GA 30092.
What is the SEC file number for this filing?
The SEC file number for this 10-Q filing is 001-10356.
Filing Stats: 4,374 words · 17 min read · ~15 pages · Grade level 19 · Accepted 2024-08-05 16:33:28
Key Financial Figures
- $1.00 — ich registered Class A Common Stock — $1.00 Par Value CRD-A New York Stock Exch
Filing Documents
- crda-20240630.htm (10-Q) — 3404KB
- crda-ex15.htm (EX-15) — 5KB
- crda-ex31_1.htm (EX-31.1) — 15KB
- crda-ex31_2.htm (EX-31.2) — 15KB
- crda-ex32_1.htm (EX-32.1) — 8KB
- crda-ex32_2.htm (EX-32.2) — 8KB
- 0000950170-24-090835.txt ( ) — 10674KB
- crda-20240630.xsd (EX-101.SCH) — 1054KB
- crda-20240630_htm.xml (XML) — 2139KB
Financial Information
Part I. Financial Information Item 1.
Financial Statements
Financial Statements: 3 Condensed Consolidated Statements of Operations (unaudited) for the three months ended June 30, 2024 and 2023 3 Condensed Consolidated Statements of Operations (unaudited) for the six months ended June 30, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive Income (unaudited) for the three and six months ended June 30, 2024 and 2023 5 Condensed Consolidated Balance Sheets (unaudited) as of June 30, 2024 and December 31, 2023 6 Condensed Consolidated Statements of Cash Flows (unaudited) for the six months ended June 30, 2024 and 2023 8 Condensed Consolidated Statements of Shareholders' Investment (unaudited) as of and for the three months ended March 31 and June 30, 2024 and 2023 9 Notes to Condensed Consolidated Financial Statements (unaudited) 11 Report of Independent Registered Public Accounting Firm 24 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 45 Item 4.
Controls and Procedures
Controls and Procedures 45
Other Information
Part II. Other Information Item 1A.
Risk Factors
Risk Factors 46 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 46 Item 5. Other Information 46 Item 6. Exhibits 47
— Financ ial Information
Part I — Financ ial Information
Financ ial Statements
Item 1. Financ ial Statements CRAWFORD & COMPANY CONDENSED CONSOLIDATED S TATEMENTS OF OPERATIONS Unaudited Three Months Ended June 30, (In thousands, except per share amounts) 2024 2023 Revenues: Revenues before reimbursements $ 314,227 $ 324,556 Reimbursements 12,626 13,073 Total Revenues 326,853 337,629 Costs and Expenses: Costs of services provided, before reimbursements 222,265 234,031 Reimbursements 12,626 13,073 Total costs of services 234,891 247,104 Selling, general, and administrative expenses 72,270 70,473 Corporate interest expense, net of interest income of $ 817 and $ 660 , respectively 4,256 4,309 Total Costs and Expenses 311,417 321,886 Other Loss, net ( 2,448 ) ( 2,192 ) Income Before Income Taxes 12,988 13,551 Provision for Income Taxes 4,486 5,206 Net Income 8,502 8,345 Net Loss Attributable to Noncontrolling Interests 82 82 Net Income Attributable to Shareholders of Crawford & Company $ 8,584 $ 8,427 Earnings Per Share - Basic: Class A Common Stock $ 0.17 $ 0.17 Class B Common Stock $ 0.17 $ 0.17 Earnings Per Share - Diluted: Class A Common Stock $ 0.17 $ 0.17 Class B Common Stock $ 0.17 $ 0.17 Weighted-Average Shares Used to Compute Basic Earnings Per Share: Class A Common Stock 29,728 28,956 Class B Common Stock 19,374 19,848 Weighted-Average Shares Used to Compute Diluted Earnings Per Share: Class A Common Stock 30,171 29,770 Class B Common Stock 19,374 19,848 (The accompanying notes are an integral part of these condensed consolidated financial statements) 3 CRAWFORD & COMPANY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Unaudited Six Months Ended June 30, (In thousands, except per share amounts) 2024 2023 Revenues: Revenues before reimbursements $ 615,881 $ 640,890 Reimbursements 24,045 24,677 Total Revenues 639,92